Advertisement
U.S. markets close in 1 hour 32 minutes

agilon health, inc. (AGL)

NYSE - Nasdaq Real Time Price. Currency in USD
6.51-0.28 (-4.12%)
As of 02:27PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Slow Stochastic

Slow Stochastic

Previous Close6.79
Open7.05
Bid6.52 x 1100
Ask6.51 x 2900
Day's Range6.47 - 6.87
52 Week Range5.63 - 29.44
Volume1,977,403
Avg. Volume5,220,515
Market Cap2.643B
Beta (5Y Monthly)0.47
PE Ratio (TTM)N/A
EPS (TTM)-0.22
Earnings DateFeb 27, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est12.69
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for AGL

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • agilon health, inc.
    ALE: Raising target price to $73.00ALLETE INC has an Investment Rating of HOLD; a target price of $73.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Low; and a Value Subrating of High.
    Rating
    Fair Value
    Economic Moat
    3 years agoArgus Research
View more
  • Zacks

    Analysts Estimate Agilon Health (AGL) to Report a Decline in Earnings: What to Look Out for

    Agilon (AGL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Business Wire

    agilon health Sets Date to Report Fourth Quarter and Full Year 2023 Financial Results

    AUSTIN, Texas, February 09, 2024--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the fourth quarter and full year 2023 after the market closes on Tuesday, February 27, 2023, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results.

  • Business Wire

    agilon health Announces Chief Medical Officer Transition

    AUSTIN, Texas, February 08, 2024--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced today that Benjamin Kornitzer, M.D., will assume a strategic role as special advisor to the company and will transition from his role as chief medical officer (CMO) effective March 1, 2024. agilon health has initiated a comprehensive search process to identify a new CMO. Until a successor is named, Karthik Rao, M.D., senior medical di